BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 24810576)

  • 1. Phosphorylation modulates clearance of alpha-synuclein inclusions in a yeast model of Parkinson's disease.
    Tenreiro S; Reimão-Pinto MM; Antas P; Rino J; Wawrzycka D; Macedo D; Rosado-Ramos R; Amen T; Waiss M; Magalhães F; Gomes A; Santos CN; Kaganovich D; Outeiro TF
    PLoS Genet; 2014 May; 10(5):e1004302. PubMed ID: 24810576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel multiplex assay for simultaneous quantification of total and S129 phosphorylated human alpha-synuclein.
    Landeck N; Hall H; Ardah MT; Majbour NK; El-Agnaf OM; Halliday G; Kirik D
    Mol Neurodegener; 2016 Aug; 11(1):61. PubMed ID: 27549140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implication of Alpha-Synuclein Phosphorylation at S129 in Synucleinopathies: What Have We Learned in the Last Decade?
    Oueslati A
    J Parkinsons Dis; 2016; 6(1):39-51. PubMed ID: 27003784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-Terminal Tyrosine Residue Modifications Modulate the Protective Phosphorylation of Serine 129 of α-Synuclein in a Yeast Model of Parkinson's Disease.
    Kleinknecht A; Popova B; Lázaro DF; Pinho R; Valerius O; Outeiro TF; Braus GH
    PLoS Genet; 2016 Jun; 12(6):e1006098. PubMed ID: 27341336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic comparison of the effects of alpha-synuclein mutations on its oligomerization and aggregation.
    Lázaro DF; Rodrigues EF; Langohr R; Shahpasandzadeh H; Ribeiro T; Guerreiro P; Gerhardt E; Kröhnert K; Klucken J; Pereira MD; Popova B; Kruse N; Mollenhauer B; Rizzoli SO; Braus GH; Danzer KM; Outeiro TF
    PLoS Genet; 2014 Nov; 10(11):e1004741. PubMed ID: 25393002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the subcellular dynamics of alpha-synuclein using photoactivation microscopy.
    Gonçalves S; Outeiro TF
    Mol Neurobiol; 2013 Jun; 47(3):1081-92. PubMed ID: 23389286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The subcellular arrangement of alpha-synuclein proteoforms in the Parkinson's disease brain as revealed by multicolor STED microscopy.
    Moors TE; Maat CA; Niedieker D; Mona D; Petersen D; Timmermans-Huisman E; Kole J; El-Mashtoly SF; Spycher L; Zago W; Barbour R; Mundigl O; Kaluza K; Huber S; Hug MN; Kremer T; Ritter M; Dziadek S; Geurts JJG; Gerwert K; Britschgi M; van de Berg WDJ
    Acta Neuropathol; 2021 Sep; 142(3):423-448. PubMed ID: 34115198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific Detection of Physiological S129 Phosphorylated α-Synuclein in Tissue Using Proximity Ligation Assay.
    Arlinghaus R; Iba M; Masliah E; Cookson MR; Landeck N
    J Parkinsons Dis; 2023; 13(2):255-270. PubMed ID: 36847016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PLK2 modulates α-synuclein aggregation in yeast and mammalian cells.
    Basso E; Antas P; Marijanovic Z; Gonçalves S; Tenreiro S; Outeiro TF
    Mol Neurobiol; 2013 Dec; 48(3):854-62. PubMed ID: 23677647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ser129D mutant alpha-synuclein induces earlier motor dysfunction while S129A results in distinctive pathology in a rat model of Parkinson's disease.
    Febbraro F; Sahin G; Farran A; Soares S; Jensen PH; Kirik D; Romero-Ramos M
    Neurobiol Dis; 2013 Aug; 56():47-58. PubMed ID: 23567651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do Lewy bodies contain alpha-synuclein fibrils? and Does it matter? A brief history and critical analysis of recent reports.
    Lashuel HA
    Neurobiol Dis; 2020 Jul; 141():104876. PubMed ID: 32339655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-synuclein phosphorylation enhances eosinophilic cytoplasmic inclusion formation in SH-SY5Y cells.
    Smith WW; Margolis RL; Li X; Troncoso JC; Lee MK; Dawson VL; Dawson TM; Iwatsubo T; Ross CA
    J Neurosci; 2005 Jun; 25(23):5544-52. PubMed ID: 15944382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limelight on alpha-synuclein: pathological and mechanistic implications in neurodegeneration.
    Wales P; Pinho R; Lázaro DF; Outeiro TF
    J Parkinsons Dis; 2013; 3(4):415-59. PubMed ID: 24270242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A powerful yeast model to investigate the synergistic interaction of α-synuclein and tau in neurodegeneration.
    Ciaccioli G; Martins A; Rodrigues C; Vieira H; Calado P
    PLoS One; 2013; 8(2):e55848. PubMed ID: 23393603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DJ-1 interactions with α-synuclein attenuate aggregation and cellular toxicity in models of Parkinson's disease.
    Zondler L; Miller-Fleming L; Repici M; Gonçalves S; Tenreiro S; Rosado-Ramos R; Betzer C; Straatman KR; Jensen PH; Giorgini F; Outeiro TF
    Cell Death Dis; 2014 Jul; 5(7):e1350. PubMed ID: 25058424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. shRNA-Based Screen Identifies Endocytic Recycling Pathway Components That Act as Genetic Modifiers of Alpha-Synuclein Aggregation, Secretion and Toxicity.
    Gonçalves SA; Macedo D; Raquel H; Simões PD; Giorgini F; Ramalho JS; Barral DC; Ferreira Moita L; Outeiro TF
    PLoS Genet; 2016 Apr; 12(4):e1005995. PubMed ID: 27123591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. α-Synuclein Decreases the Abundance of Proteasome Subunits and Alters Ubiquitin Conjugates in Yeast.
    Popova B; Galka D; Häffner N; Wang D; Schmitt K; Valerius O; Knop M; Braus GH
    Cells; 2021 Aug; 10(9):. PubMed ID: 34571878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Posttranslational Modifications and Clearing of α-Synuclein Aggregates in Yeast.
    Popova B; Kleinknecht A; Braus GH
    Biomolecules; 2015 Apr; 5(2):617-34. PubMed ID: 25915624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prominent astrocytic alpha-synuclein pathology with unique post-translational modification signatures unveiled across Lewy body disorders.
    Altay MF; Liu AKL; Holton JL; Parkkinen L; Lashuel HA
    Acta Neuropathol Commun; 2022 Nov; 10(1):163. PubMed ID: 36371251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous oligodendroglial alpha-synuclein and TPPP/p25α orchestrate alpha-synuclein pathology in experimental multiple system atrophy models.
    Mavroeidi P; Arvanitaki F; Karakitsou AK; Vetsi M; Kloukina I; Zweckstetter M; Giller K; Becker S; Sorrentino ZA; Giasson BI; Jensen PH; Stefanis L; Xilouri M
    Acta Neuropathol; 2019 Sep; 138(3):415-441. PubMed ID: 31011860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.